| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.0006 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.16 | 0.6 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.093 | 0.2 |